Dose-adjusted EPOCH plus /- rituximab in older patients with high grade diffuse large B-cell lymphoma, Burkitt and T-cell lymphoma: An effective regimen with acceptable toxicity profile Meeting Abstract


Authors: Owens, C. N.; Migliacci, J. C.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Younes, A.; Zelenetz, A. D.; Hamlin, P. A.
Abstract Title: Dose-adjusted EPOCH plus /- rituximab in older patients with high grade diffuse large B-cell lymphoma, Burkitt and T-cell lymphoma: An effective regimen with acceptable toxicity profile
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349243505093
PROVIDER: wos
DOI: 10.1182/blood.V124.21.4450.4450
Notes: Meeting Abstract: 4450 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carol Portlock
    204 Portlock
  2. Ariela Noy
    351 Noy
  3. Maria Lia Palomba
    415 Palomba
  4. Steven M Horwitz
    645 Horwitz
  5. Andrew D Zelenetz
    767 Zelenetz
  6. Alison Moskowitz
    339 Moskowitz
  7. Paul Hamlin
    277 Hamlin
  8. Matthew J Matasar
    289 Matasar
  9. David J Straus
    356 Straus
  10. Jocelyn C Migliacci
    104 Migliacci
  11. Anas Younes
    319 Younes
  12. Colette Ngozi Owens
    66 Owens
Related MSK Work